Insight Wealth Strategies LLC Reduces Position in McKesson Corporation $MCK

Insight Wealth Strategies LLC lowered its position in McKesson Corporation (NYSE:MCK) by 93.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 374 shares of the company’s stock after selling 5,351 shares during the quarter. Insight Wealth Strategies LLC’s holdings in McKesson were worth $287,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the company. Horizon Investments LLC boosted its stake in McKesson by 125.4% in the fourth quarter. Horizon Investments LLC now owns 8,679 shares of the company’s stock valued at $7,119,000 after buying an additional 4,828 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its stake in McKesson by 18.7% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 31,526 shares of the company’s stock worth $25,860,000 after acquiring an additional 4,964 shares in the last quarter. Concurrent Investment Advisors LLC raised its stake in McKesson by 62.9% during the fourth quarter. Concurrent Investment Advisors LLC now owns 3,158 shares of the company’s stock worth $2,590,000 after acquiring an additional 1,219 shares in the last quarter. Adelphi Trust Co bought a new position in shares of McKesson in the fourth quarter worth about $1,177,000. Finally, Merit Financial Group LLC lifted its holdings in shares of McKesson by 12.3% in the fourth quarter. Merit Financial Group LLC now owns 20,448 shares of the company’s stock worth $16,774,000 after acquiring an additional 2,238 shares during the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a report on Saturday, June 27th. Morgan Stanley reissued an “overweight” rating on shares of McKesson in a research note on Friday, August 7th. Wells Fargo & Company raised their target price on shares of McKesson from $812.00 to $933.00 and gave the company an “equal weight” rating in a research report on Tuesday. JPMorgan Chase & Co. decreased their target price on shares of McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating on the stock in a research note on Friday, May 8th. Finally, Citigroup upped their price target on shares of McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a report on Friday, July 24th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $977.00.

Insider Transactions at McKesson

In related news, Director Bradley E. Lerman sold 301 shares of McKesson stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $892.33, for a total value of $268,591.33. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 133 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $764.00, for a total value of $101,612.00. Following the completion of the sale, the chief accounting officer owned 632 shares in the company, valued at $482,848. The trade was a 17.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 29,049 shares of company stock worth $22,530,626. 0.06% of the stock is currently owned by insiders.

McKesson Trading Down 2.7%

NYSE:MCK opened at $877.21 on Thursday. The stock has a market cap of $102.27 billion, a P/E ratio of 23.47, a price-to-earnings-growth ratio of 1.77 and a beta of 0.30. The stock’s 50-day moving average is $809.56 and its 200-day moving average is $842.36. McKesson Corporation has a 1-year low of $659.86 and a 1-year high of $999.00.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $9.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The business had revenue of $105.38 billion during the quarter, compared to analyst estimates of $103.88 billion. During the same quarter last year, the business earned $8.26 EPS. The firm’s quarterly revenue was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, equities analysts forecast that McKesson Corporation will post 44.65 EPS for the current year.

McKesson Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be given a $0.94 dividend. This is a boost from McKesson’s previous quarterly dividend of $0.82. The ex-dividend date is Tuesday, September 1st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio is presently 8.78%.

Key Headlines Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: J.P. Morgan reiterated a Buy rating on McKesson, adding to the bullish analyst support for the stock. McKesson Gets a Buy from J.P. Morgan
• Positive Sentiment: Citi maintained its Buy rating, reinforcing confidence in McKesson’s earnings outlook following its latest quarterly report. Citi Keeps Buy Rating on McKesson
• Positive Sentiment: McKesson recently exceeded quarterly earnings and revenue expectations, with EPS of $9.93 and revenue of $105.38 billion. Revenue increased 7.7% year over year, while fiscal 2027 EPS guidance remains $44.20–$45.00.
• Positive Sentiment: The company raised its quarterly dividend to $0.94 per share from $0.82, signaling confidence in cash generation and shareholder returns.
• Neutral Sentiment: Wells Fargo raised its price target to $933 from $812 but retained an Equal Weight rating, suggesting analysts see some additional upside while remaining cautious about valuation. Wells Fargo Raises McKesson Price Target
• Negative Sentiment: Director Bradley E. Lerman sold 301 shares worth approximately $268,600. The relatively small transaction may pressure sentiment but does not materially alter McKesson’s fundamentals.
• Negative Sentiment: McKesson’s strong rally has brought the stock near its 52-week high, increasing concerns that favorable earnings, analyst targets and growth expectations may already be reflected in the share price.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.